Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Avicanna ( (TSE:AVCN) ) is now available.
Avicanna Inc. announced it will hold a conference call to discuss its Full Year 2024 financial results, which will be filed after the market closes on March 31, 2025. This announcement highlights Avicanna’s ongoing commitment to transparency and communication with its stakeholders, potentially impacting its market positioning and investor relations positively.
More about Avicanna
Avicanna Inc. is a biopharmaceutical company that focuses on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products. The company operates in the global medical and pharmaceutical market segments, offering a range of proprietary products under its Medical Cannabis formulary, medical cannabis care platform, pharmaceutical pipeline, and active pharmaceutical ingredients business pillars.
YTD Price Performance: 13.64%
Average Trading Volume: 122,741
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $26.98M
For detailed information about AVCN stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue